MoonLake Immunotherapeutics Class A stock price
NASDAQ:MLTX · Nasdaq · Healthcare · sector #16MoonLake Immunotherapeutics Class A's chart data is dated 2026-10-21. Recorded technical signals: RSI rebound, MACD bullish cross, Mean reversion. The display ticker is MLTX.
MoonLake Immunotherapeutics Class A last closed at $10.65 (+3.20%) on 2026-10-21. Signals today: RSI rebound, MACD bullish cross, Mean reversion. Listed on Nasdaq. Trailing 12 months PER is -3.0×. Its overall grade ranks 533 of 727 stocks in Healthcare.
About this company
MoonLake Immunotherapeutics Class A last closed at $10.65 (+3.20%) on 2026-10-21. Signals today: RSI rebound, MACD bullish cross, Mean reversion. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall C · 533/727
Valuation grade A-
Related stocks
- NovartisCompetitor
- AbbVieCompetitor
- Johnson & JohnsonCompetitor
About MoonLake Immunotherapeutics Class A
- What technical signals does MoonLake Immunotherapeutics Class A (MLTX) have?
- MoonLake Immunotherapeutics Class A current technical signals: RSI rebound, MACD bullish cross, Mean reversion.
- Is MoonLake Immunotherapeutics Class A a cup-and-handle pattern?
- No. MoonLake Immunotherapeutics Class A has no valid Cup signal right now.
- What published figures are available for MoonLake Immunotherapeutics Class A?
- Market cap: $928.14M. Trailing 12 months PER: -3.0×. Latest quarter PBR: 1.84×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Turn what you saw on this name into a strategy
Ask Q about MoonLake Immunotherapeutics Class A, or open the plan table on the main site.
Ask Q about MoonLake Immunotherapeutics Class A.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.